Drug developer Columbia Laboratories Inc. maintained its 2008 revenue forecast Wednesday, saying it will meet its goals despite difficult economic conditions.
Columbia stuck to its March forecast of $35 million to $40 million in revenue for the year, which implies growth of 18 percent to 35 percent. The company reported $29.6 million in revenue in 2007.
On average, analysts expected $36.3 million in revenue, according to Thomson Reuters.
Columbia stuck to its March forecast of $35 million to $40 million in revenue for the year, which implies growth of 18 percent to 35 percent. The company reported $29.6 million in revenue in 2007.
On average, analysts expected $36.3 million in revenue, according to Thomson Reuters.
0 comments:
Post a Comment